Hrt Financial LP Pacira Bio Sciences, Inc. Transaction History

Hrt Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$35.53 - $43.38 $5.44 Million - $6.64 Million	-153,077 Reduced 95.84%	6,645 $271,000
Q4 2022 Feb 10, 2023	BUY	$38.19 - $57.45 $5.26 Million - $7.91 Million	137,685 Added 624.79%	159,722 $6.17 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $1.13 Million - $1.3 Million	22,037 New	22,037 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $918,961 - $1.19 Million	-19,157 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $1.92 Million - $2.15 Million	-35,147 Reduced 64.72%	19,157 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $3.21 Million - $3.8 Million	54,304 New	54,304 $3.3 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $288,228 - $371,736	-7,938 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $283,069 - $357,130	7,938 New	7,938 $302,000
Q1 2019 May 14, 2019	SELL	$36.47 - $42.17 $286,873 - $331,709	-7,866 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$41.31 - $52.16 $324,944 - $410,290	7,866 New	7,866 $338,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.